Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.66 USD | -2.56% |
|
-0.91% | -4.33% |
06-25 | Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval | MT |
06-25 | Roche: approval of Ocrevus SC in Europe | CF |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ROCHE HOLDING AG | Other Pharmaceuticals | -2.56% | -0.91% | -4.33% | -9.46% | -0.89% | 229B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- ROG Stock
- RHHBY Stock
- Charts Roche Holding AG
- Comparison Chart